Congress extends prematurity research, mandates federal study on premature birth costs

What it does

This bill extends federal funding and research authority for prematurity studies through 2029 (previously set to expire after 2023), mandates the creation of an interagency working group on preterm birth within 18 months, and requires the National Academies of Sciences to conduct a comprehensive study of premature births in the U.S.—including costs, risk factors, detection opportunities, and treatment strategies—and report findings to Congress within 24 months. The bill benefits pregnant people and families affected by premature birth through expanded research, better detection methods, and evidence-based policy recommendations.

Why we flagged it

The bill's sole operative mechanism is extending and strengthening federal research authority on prematurity—a straightforward reauthorization with added mandates for interagency coordination and evidence-gathering. No deregulation, tax carve-outs, or private-sector giveaways are present.

What the text implies

• The mandatory 18-month timeline for the interagency working group creates a hard deadline for federal coordination on prematurity prevention, potentially accelerating policy development.
• The National Academies study requirement (24-month completion) will produce peer-reviewed evidence on premature birth costs and prevention strategies, which may inform future Medicaid, Medicare, and maternal health policy.
• The study's focus on 'precision medicine and preventative care approaches' and 'behavioral and biological influences' may drive future research funding toward personalized intervention models rather than population-level prevention.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill extends research funding for a serious maternal and infant health condition, mandates evidence-gathering on costs and prevention strategies, and requires actionable recommendations to Congress—all aimed at reducing premature births and improving outcomes for affected families. No restrictions on citizens' rights or protections are imposed.

Who stands to gain

• National Institutes of Health (research funding continuation)
• National Academies of Sciences, Engineering, and Medicine (study contract)
• Academic medical centers and maternal health research institutions

Named in the bill

National Institutes of Health (NIH), National Academies of Sciences, Engineering, and Medicine, Secretary of Health and Human Services, House Committee on Energy and Commerce, Senate Committee on Finance, Senate Committee on Health, Education, Labor, and Pensions, Public Law 115–328 (PREEMIE Reauthorization Act of 2018)

Where it stands

40 cosponsors: 28 Democrats, 12 Republicans.

• Feb 11, 2025 — Introduced · Congress.gov: “Introduced in House”
• Feb 11, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

13 lobbying clients named this bill on 15 disclosure filings across 3 quarters, Dec 2025 to Jun 2026. Those filings disclosed $2,049,599 in lobbying spend. A filing names 17 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 94% of bills with at least one filing.

Robin Kelly, the sponsor, reported $539,150 in PAC receipts in the 2026 cycle.

• American Academy of Family Physicians — $667,881 on 1 filing
• American Federation of Teachers — $410,000 on 1 filing
• American Academy of Pediatrics — $320,000 on 1 filing
• Catholic Health Association of the United States — $240,651 on 1 filing
• Hadassah, the Women's Zionist Organization of America, Inc. — $120,000 on 2 filings

Lobbying Disclosure Act filings through Jul 22, 2026. A filing shows who paid to lobby on a bill it names, not what changed.